Heavy metal toxicity and the aetiology of glaucoma.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
01
10
2019
accepted:
06
10
2019
pubmed:
21
11
2019
medline:
22
6
2021
entrez:
21
11
2019
Statut:
ppublish
Résumé
Despite recent advances, our understanding of the aetiological mechanisms underlying glaucoma remains incomplete. Heavy metals toxicity has been linked to the development of neurodegenerative diseases and various ocular pathologies. Given the similarities in pathophysiology between glaucoma and some neurodegenerative disorders, it is plausible that heavy metal toxicity may play a role in the development of glaucoma. Heavy metal exposure may be occupational, or through water or dietary contamination. In this report, we review mechanisms for systemic and neurotoxicity for arsenic, cadmium, chromium, cobalt, lead, mercury, and manganese, and weigh the evidence for an association between glaucoma and the accumulation of heavy metals either in ocular tissues or in the central nervous system. 摘要: 尽管近年来关于青光眼的发病机制的研究有所进展, 但我们对其认识仍不全面。已发现重金属毒性与神经的退行性病变与多种眼部疾病发生具有相关性。由于青光眼与一些退行性神经病变的病理生理机制相似, 因此推测重金属毒性可能与青光眼的发展有关。重金属暴露可能是职业性的原因, 也可能通过水及食物的污染。在这篇报道中我们分析了砷, 镉, 铬, 钴, 铅, 汞和锰对于全身和神经系统毒性的病理发病机制, 评估了重金属在眼部与中枢神经系统中的蓄积与青光眼发病之间的相关性。.
Autres résumés
Type: Publisher
(chi)
摘要: 尽管近年来关于青光眼的发病机制的研究有所进展, 但我们对其认识仍不全面。已发现重金属毒性与神经的退行性病变与多种眼部疾病发生具有相关性。由于青光眼与一些退行性神经病变的病理生理机制相似, 因此推测重金属毒性可能与青光眼的发展有关。重金属暴露可能是职业性的原因, 也可能通过水及食物的污染。在这篇报道中我们分析了砷, 镉, 铬, 钴, 铅, 汞和锰对于全身和神经系统毒性的病理发病机制, 评估了重金属在眼部与中枢神经系统中的蓄积与青光眼发病之间的相关性。.
Identifiants
pubmed: 31745328
doi: 10.1038/s41433-019-0672-z
pii: 10.1038/s41433-019-0672-z
pmc: PMC7002597
doi:
Substances chimiques
Metals, Heavy
0
Cadmium
00BH33GNGH
Mercury
FXS1BY2PGL
Arsenic
N712M78A8G
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
129-137Subventions
Organisme : Medical Research Council
ID : MR/T040912/1
Pays : United Kingdom
Références
Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86:238–42.
pubmed: 11815354
pmcid: 1771026
doi: 10.1136/bjo.86.2.238
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–7.
pubmed: 16488940
pmcid: 1856963
doi: 10.1136/bjo.2005.081224
Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295–304.
pubmed: 25533656
doi: 10.1016/S0140-6736(14)62111-5
Leske MC, Heijl A, Hyman L, Bengtsson B, Group EMGT. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106:2144–53.
pubmed: 10571351
doi: 10.1016/S0161-6420(99)90497-9
Khawaja AP, Bailey JNC, Wareham NJ, Scott RA, Simcoe M, Igo RP, et al. Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma. Nat Genet. 2018;50:778.
pubmed: 29785010
pmcid: 5985943
doi: 10.1038/s41588-018-0126-8
Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016;100:86–93.
pubmed: 26286821
doi: 10.1136/bjophthalmol-2015-307223
Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711–20.
pubmed: 15158634
doi: 10.1016/S0140-6736(04)16257-0
Chaturvedi N, Hedley-Whyte ET, Dreyer EB. Lateral geniculate nucleus in glaucoma. Am J Ophthalmol. 1993;116:182–8.
pubmed: 8352303
doi: 10.1016/S0002-9394(14)71283-8
Chen WW, Wang N, Cai S, Fang Z, Yu M, Wu Q, et al. Structural brain abnormalities in patients with primary open-angle glaucoma: a study with 3T MR imaging. Invest Ophthalmol Vis Sci. 2013;54:545–54.
pubmed: 23258150
doi: 10.1167/iovs.12-9893
Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci USA. 2010;107:5196–201.
pubmed: 20194762
pmcid: 2841892
doi: 10.1073/pnas.0913141107
Lawlor M, Danesh-Meyer H, Levin LA, Davagnanam I, De Vita E, Plant GT. Glaucoma and the brain: trans-synaptic degeneration, structural change, and implications for neuroprotection. Survey of ophthalmology. 2018;63:296–306.
pubmed: 28986311
doi: 10.1016/j.survophthal.2017.09.010
Sivak JM. The aging eye: common degenerative mechanisms between the Alzheimer’s brain and retinal diseasecommon degenerative mechanisms between brain and retina. Investig Ophthalmol Vis Sci. 2013;54:871–80.
doi: 10.1167/iovs.12-10827
Danesh-Meyer HV, Levin LA. Glaucoma as a neurodegenerative disease. J Neuroophthalmol. 2015;35:S22–8.
pubmed: 26274833
doi: 10.1097/WNO.0000000000000293
Gupta N, Yücel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18:110–4.
pubmed: 17301611
doi: 10.1097/ICU.0b013e3280895aea
Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med. 1986;315:485–7.
pubmed: 3736630
doi: 10.1056/NEJM198608213150804
Ghiso JA, Doudevski I, Ritch R, Rostagno AA. Alzheimer’s disease and glaucoma: mechanistic similarities and differences. J Glaucoma. 2013;22:S36.
pubmed: 23733125
pmcid: 3955061
doi: 10.1097/IJG.0b013e3182934af6
Keenan TD, Goldacre R, Goldacre MJ. Associations between primary open angle glaucoma, Alzheimer’s disease and vascular dementia: record linkage study. Br J Ophthalmol. 2015;99:524–7.
pubmed: 25370081
doi: 10.1136/bjophthalmol-2014-305863
Noble W, Hanger DP, Miller CC, Lovestone S. The importance of tau phosphorylation for neurodegenerative diseases. Frontiers in neurology. 2013;4:83.
pubmed: 23847585
pmcid: 3696910
Carreras FJ. Pathogenesis of glaucoma: how to prevent ganglion cell from axonal destruction? Neural Regen Res. 2014;9:2046.
pubmed: 25657719
pmcid: 4316466
doi: 10.4103/1673-5374.147928
Carreras FJ. Glaucoma and amyotrophic lateral sclerosis, two kindred diseases? Neural Regen Res. 2016;11:1415.
pubmed: 27857740
pmcid: 5090839
doi: 10.4103/1673-5374.191211
Li Y, Li D, Ying X, Khaw PT, Raisman G. An energy theory of glaucoma. Glia. 2015;63:1537–52.
pubmed: 25808326
doi: 10.1002/glia.22825
Couratier P, Corcia P, Lautrette G, Nicol M, Preux P-M, Marin B. Epidemiology of amyotrophic lateral sclerosis: a review of literature. Rev Neurol. 2016;172:37–45.
pubmed: 26727307
doi: 10.1016/j.neurol.2015.11.002
Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223–6.
pubmed: 20428114
doi: 10.1038/nature08971
Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295:1077–9.
pubmed: 11834836
doi: 10.1126/science.1066901
Lee HJ, Park MK, Seo YR. Pathogenic mechanisms of heavy metal induced-Alzheimer’s disease. Toxicol Environ Health Sci. 2018;10:1–10.
doi: 10.1007/s13530-018-0340-x
Park J-H, Lee D-W, Park KS, Joung H. Serum trace metal levels in Alzheimer’s disease and normal control groups. Am J Alzheimers Dis Dement. 2014;29:76–83.
doi: 10.1177/1533317513506778
Chen L, Liu L, Huang S. Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5. Free Radic Biol Med. 2008;45:1035–44.
pubmed: 18703135
doi: 10.1016/j.freeradbiomed.2008.07.011
Chen S, Xu Y, Xu B, Guo M, Zhang Z, Liu L, et al. CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death. J Neurochem. 2011;119:1108–18.
pubmed: 21933187
pmcid: 3217117
doi: 10.1111/j.1471-4159.2011.07493.x
Lopez E, Figueroa S, Oset‐Gasque MJ, Gonzalez MP. Apoptosis and necrosis: two distinct events induced by cadmium in cortical neurons in culture. Br J Pharm. 2003;138:901–11.
doi: 10.1038/sj.bjp.0705111
Syme CD, Viles JH. Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Aβ) of Alzheimer’s disease. Biochim Biophys Acta. 2006;1764:246–56.
pubmed: 16266835
doi: 10.1016/j.bbapap.2005.09.012
Jiang L-F, Yao T-M, Zhu Z-L, Wang C, Ji L-N. Impacts of Cd (II) on the conformation and self-aggregation of Alzheimer’s tau fragment corresponding to the third repeat of microtubule-binding domain. Biochim Biophys Acta. 2007;1774:1414–21.
pubmed: 17920001
doi: 10.1016/j.bbapap.2007.08.014
Min J, Min K. Blood cadmium levels and Alzheimer’s disease mortality risk in older US adults. Environ Health. 2016;15:69.
pubmed: 27301955
pmcid: 4908725
doi: 10.1186/s12940-016-0155-7
Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci. 2015;9:124.
pubmed: 25914621
pmcid: 4392704
doi: 10.3389/fncel.2015.00124
Jang M, Kim S-A, Park EY, Lee KY, Shin S, Kim JE, et al. The association between heavy metals in food and Alzheimer’s disease in Korean elderly people. FASEB J. 2013;27:616.4–616.4.
Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010;171:1126–33.
pubmed: 20406759
pmcid: 2877471
doi: 10.1093/aje/kwq063
Roos PM, Vesterberg O, Syversen T, Flaten TP, Nordberg M. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biol Trace Elem Res. 2013;151:159–70.
pubmed: 23225075
doi: 10.1007/s12011-012-9547-x
Bar-Sela S, Reingold S, Richter ED. Amyotrophic lateral sclerosis in a battery-factory worker exposed to cadmium. Int J Occup Environ Health. 2001;7:109–12.
pubmed: 11373040
doi: 10.1179/oeh.2001.7.2.109
Vinceti M, Filippini T, Mandrioli J, Violi F, Bargellini A, Weuve J, Fini N, Grill P, Michalke B. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study. Journal of Trace Elements in Medicine and Biology. 2017;43:121–5.
pubmed: 28089071
pmcid: 5495626
doi: 10.1016/j.jtemb.2016.12.012
D’Amico E, Factor-Litvak P, Santella RM, Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med. 2013;65:509–27.
pubmed: 23797033
doi: 10.1016/j.freeradbiomed.2013.06.029
Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP. Lead exposure and amyotrophic lateral sclerosis. Epidemiology. 2002;13:311–9.
pubmed: 11964933
doi: 10.1097/00001648-200205000-00012
Cabell L, Ferguson C, Luginbill D, Kern M, Weingart A, Audesirk G. Differential induction of heme oxygenase and other stress proteins in cultured hippocampal astrocytes and neurons by inorganic lead. Toxicol Appl Pharm. 2004;198:49–60.
doi: 10.1016/j.taap.2004.03.001
Qian Y, Zheng Y, Ramos KS, Tiffany-Castiglioni E. The involvement of copper transporter in lead-induced oxidative stress in astroglia. Neurochem Res. 2005;30:429–38.
pubmed: 16076012
doi: 10.1007/s11064-005-2677-1
Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect. 2005;113:1250–6.
pubmed: 16140637
pmcid: 1280411
doi: 10.1289/ehp.7567
Gibb WR, Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51:745–52.
pubmed: 2841426
pmcid: 1033142
doi: 10.1136/jnnp.51.6.745
Kuhn W, Winkel R, Woitalla D, Meves S, Przuntek H, Muller T. High prevalence of parkinsonism after occupational exposure to lead‐sulfate batteries. Neurology. 1998;50:1885–6.
pubmed: 9633752
doi: 10.1212/WNL.50.6.1885
Coon S, Stark A, Peterson E, Gloi A, Kortsha G, Pounds J, et al. Whole-body lifetime occupational lead exposure and risk of Parkinson’s disease. Environ Health Perspect. 2006;114:1872–6.
pubmed: 17185278
pmcid: 1764163
doi: 10.1289/ehp.9102
Gorell JM, Peterson EL, Rybicki BA, Johnson CC. Multiple risk factors for Parkinson’s disease. J Neurol Sci. 2004;217:169–74.
pubmed: 14706220
doi: 10.1016/j.jns.2003.09.014
Perl DP, Olanow CW. The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol. 2007;66:675–82.
pubmed: 17882011
doi: 10.1097/nen.0b013e31812503cf
Dehghanifiroozabadi M, Noferesti P, Amirabadizadeh A, Nakhaee S, Aaseth J, Noorbakhsh F, et al. Blood lead levels and multiple sclerosis: a case-control study. Mult Scler Relat Disord. 2019;27:151–5.
pubmed: 30384201
doi: 10.1016/j.msard.2018.10.010
Aliomrani M, Sahraian MA, Shirkhanloo H, Sharifzadeh M, Khoshayand MR, Ghahremani MH. Correlation between heavy metal exposure and GSTM1 polymorphism in Iranian multiple sclerosis patients. Neurol Sci. 2017;38:1271–8.
pubmed: 28432518
doi: 10.1007/s10072-017-2934-5
Vijaya L, George R, Baskaran M, Arvind H, Raju P, Ramesh SV, et al. Prevalence of primary open-angle glaucoma in an urban south Indian population and comparison with a rural population: the Chennai Glaucoma Study. Ophthalmology. 2008;115:648–654. e1.
pubmed: 17664010
doi: 10.1016/j.ophtha.2007.04.062
Garudadri C, Senthil S, Khanna RC, Sannapaneni K, Rao HBL. Prevalence and risk factors for primary glaucomas in adult urban and rural populations in the Andhra Pradesh Eye Disease Study. Ophthalmology. 2010;117:1352–9.
pubmed: 20188420
doi: 10.1016/j.ophtha.2009.11.006
Gherardi M, Pontalti F, Vianello G, Antisari LV. Heavy metals in the soil-plant system: monitoring urban and extra-urban parks in the Emilia Romagna Region (Italy). Agrochimica. 2009;53:196–208.
Antisari LV, Orsini F, Marchetti L, Vianello G, Gianquinto G. Heavy metal accumulation in vegetables grown in urban gardens. Agron Sustain Dev. 2015;35:1139–47.
doi: 10.1007/s13593-015-0308-z
Apeagyei E, Bank MS, Spengler JD. Distribution of heavy metals in road dust along an urban-rural gradient in Massachusetts. Atmos Environ. 2011;45:2310–23.
doi: 10.1016/j.atmosenv.2010.11.015
Shabbaj II, Alghamdi MA, Shamy M, Hassan SK, Alsharif MM, Khoder MI. Risk assessment and implication of human exposure to road dust heavy metals in Jeddah, Saudi Arabia. Int J Environ Res Public Health. 2017;15:36.
pmcid: 5799873
doi: 10.3390/ijerph15010036
Apostoli P, Catalani S, Zaghini A, Mariotti A, Poliani PL, Vielmi V, et al. High doses of cobalt induce optic and auditory neuropathy. Exp Toxicol Pathol. 2013;65:719–27.
pubmed: 23069009
doi: 10.1016/j.etp.2012.09.006
Rizzetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, et al. Loss of sight and sound. Could it be the hip? Lancet. 2009;373:1052.
pubmed: 19304018
doi: 10.1016/S0140-6736(09)60490-6
Bradberry SM, Wilkinson JM, Ferner RE. Systemic toxicity related to metal hip prostheses. Clin Toxicol. 2014;52:837–47.
doi: 10.3109/15563650.2014.944977
Catalani S, Rizzett MC, Padovani A, Apostoli P. Neurotoxicity of cobalt. Hum Exp Toxicol. 2012;31:421–37.
pubmed: 21729976
doi: 10.1177/0960327111414280
Ng SK, Ebneter A, Gilhotra JS. Hip-implant related chorio-retinal cobalt toxicity. Indian J Ophthalmol. 2013;61:35.
pubmed: 23275221
pmcid: 3554995
doi: 10.4103/0301-4738.105053
Vetalice JA. Orthopaedic industry annual report—focus on joint replacement. OrthoKnow. 2012;1–8.
Unsworth-Smith T, Khan JC, Khan RJ, Chelva E, Lim CA, Haebich S, Trevenen ML. Impact of Raised Serum Cobalt Levels From Recalled Articular Surface Replacement Hip Prostheses on the Visual Pathway. The Journal of arthroplasty. 2017;32:3147–51.
pubmed: 28647139
doi: 10.1016/j.arth.2017.04.064
Monies A, Prost M. Experimental studies on lesions of eye tissues in cobalt intoxication. Klin Ocz. 1994;96:135–9.
Carelli V, Barboni P, Sadun AA. Mitochondrial ophthalmology. Mitochondrial Med Oxf Inf Healthc. 2006;105–42.
Prozialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006;79:1493–506.
pubmed: 16765992
doi: 10.1016/j.lfs.2006.05.007
Gonzalez-Reimers E, Martín-González C, Galindo-Martín L, Aleman-Valls MR, Velasco-Vázquez J, Arnay-de-la-Rosa M, et al. Lead, cadmium and zinc in hair samples: relationship with dietary habits and urban environment. Biol Trace Elem Res. 2014;157:205–10.
pubmed: 24464602
doi: 10.1007/s12011-014-9896-8
Robson TC, Braungardt CB, Rieuwerts J, Worsfold P. Cadmium contamination of agricultural soils and crops resulting from sphalerite weathering. Environ Pollut. 2014;184:283–9.
pubmed: 24077256
doi: 10.1016/j.envpol.2013.09.001
Clarkson TW, Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol. 2006;36:609–62.
pubmed: 16973445
doi: 10.1080/10408440600845619
Karri V, Schuhmacher M, Kumar V. Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: a general review of metal mixture mechanism in brain. Environ Toxicol Pharm. 2016;48:203–13.
doi: 10.1016/j.etap.2016.09.016
Lee SH, Kang EM, Kim GA, Kwak SW, Kim JM, Bae HW, et al. Three toxic heavy metals in open-angle glaucoma with low-teen and high-teen intraocular pressure: a cross-sectional study from South Korea. PLoS ONE. 2016;11:e0164983.
pubmed: 27768724
pmcid: 5074541
doi: 10.1371/journal.pone.0164983
Chung HS, Harris A, Evans DW, Kagemann L, Garzozi HJ, Martin B. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43:S43–50.
pubmed: 10416746
doi: 10.1016/S0039-6257(99)00050-8
Clarkson TW, Magos L, Myers GJ. The toxicology of mercury—current exposures and clinical manifestations. N Engl J Med. 2003;2003:1731–7.
doi: 10.1056/NEJMra022471
Murphy TH, Malouf AT, Sastre A, Schnaar RL, Coyle JT. Calcium-dependent glutamate cytotoxicity in a neuronal cell line. Brain Res. 1988;444:325–32.
pubmed: 2896063
doi: 10.1016/0006-8993(88)90941-9
Kaźmierczak K, Malukiewicz G, Lesiewska-Junk H, Laudencka A, Szady-Grad M, Klawe J, et al. Blood plasma levels of microelements in patients with history of optic neuritis. Curr Eye Res. 2014;39:93–8.
pubmed: 24083481
doi: 10.3109/02713683.2013.833244
Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18:321–36.
pubmed: 7744317
doi: 10.1016/0891-5849(94)00159-H
Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003;14:86–90.
pubmed: 12698048
doi: 10.1097/00055735-200304000-00006
Fan N, Wang P, Tang L, Liu X. “Ocular Blood Flow and Normal Tension Glaucoma,” BioMed Research International, 2015;2015:308505.
Kjellström T. Exposure and accumulation of cadmium in populations from Japan, the United States, and Sweden. Environ Health Perspect. 1979;28:169.
pubmed: 226355
pmcid: 1637502
doi: 10.1289/ehp.28-1637502
Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111:1641–8.
pubmed: 15350316
Clarkson TW. Metal toxicity in the central nervous system. Environ Health Perspect. 1987;75:59.
pubmed: 3319566
pmcid: 1474439
doi: 10.1289/ehp.877559
Cooper GP, Suszkiw JB, Manalis RS. Heavy metals: effects on synaptic transmission. Neurotoxicology. 1984;5:247–66.
pubmed: 6097846
Goyer RA. Results of lead research: prenatal exposure and neurological consequences. Environ Health Perspect. 1996;104:1050.
pubmed: 8930545
pmcid: 1469478
doi: 10.1289/ehp.961041050
Landrigan PJ. Pediatric lead poisoning: is there a threshold? Public Health Rep. 2000;115:530.
pubmed: 11354335
pmcid: 1308623
doi: 10.1093/phr/115.6.530
Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998;106:1–8.
pubmed: 9417769
pmcid: 1532948
doi: 10.1289/ehp.981061
Cadet JL, Karen IB. “Environmental Toxins And Disorders Of The Nervous System.” Neurology and Clinical Neuroscience. Mosby, 2007;1477–88.
Arvidson B. Retrograde axonal transport of cadmium in the rat hypoglossal nerve. Neurosci Lett. 1985;62:45–9.
pubmed: 4069452
doi: 10.1016/0304-3940(85)90282-4
Erie JC, Butz JA, Good JA, Erie EA, Burritt MF, Cameron JD. Heavy metal concentrations in human eyes. Am J Ophthalmol. 2005;139:888–93.
pubmed: 15860295
doi: 10.1016/j.ajo.2004.12.007
Goyer RA. Toxic and essential metal interactions. Annu Rev Nutr. 1997;17:37–50.
pubmed: 9240918
doi: 10.1146/annurev.nutr.17.1.37
Simons TJ. Lead-calcium interactions in cellular lead toxicity. Neurotoxicology. 1993;14:77–85.
pubmed: 8247414
Baruah JK, Rasool CG, Bradley WG, Munsat TL. Retrograde axonal transport of lead in rat sciatic nerve. Neurology. 1981;31:612–612.
pubmed: 7194976
doi: 10.1212/WNL.31.5.612
Ekinci M, Ceylan E, Çağatay HH, Keleş S, Altınkaynak H, Kartal B, et al. Occupational exposure to lead decreases macular, choroidal, and retinal nerve fiber layer thickness in industrial battery workers. Curr Eye Res. 2014;39:853–8.
pubmed: 24502601
doi: 10.3109/02713683.2013.877934
Ekinci M, Ceylan E, Keleş S, Çağatay HH, Apil A, Tanyıldız B, et al. Toxic effects of chronic mercury exposure on the retinal nerve fiber layer and macular and choroidal thickness in industrial mercury battery workers. Med Sci Monit. 2014;20:1284.
pubmed: 25056093
pmcid: 4136938
doi: 10.12659/MSM.890756
Nelke KH, Mulak M, Łuczak K, Pawlak W, Nienartowicz J, Szumny D, Kochman M, Gerber H Occurrence and Exposure to Lead and Cadmium and Their Environmental Influence on Eyesight. Polish Journal of Environmental Studies. 2015;24.
doi: 10.15244/pjoes/39551
Schaumberg DA, Mendes F, Balaram M, Dana MR, Sparrow D, Hu H. Accumulated lead exposure and risk of age-related cataract in men. JAMA. 2004;292:2750–4.
pubmed: 15585735
doi: 10.1001/jama.292.22.2750
Yuki K, Dogru M, Imamura Y, Kimura I, Ohtake Y, Tsubota K. Lead accumulation as possible risk factor for primary open-angle glaucoma. Biol Trace Elem Res. 2009;132:1.
pubmed: 19390789
doi: 10.1007/s12011-009-8376-z
Albrecht J, Matyja E. Glutamate: a potential mediator of inorganic mercury neurotoxicity. Metab Brain Dis. 1996;11:175–84.
pubmed: 8776719
doi: 10.1007/BF02069504
Salonen JT, Seppänen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148:265–73.
pubmed: 10657561
doi: 10.1016/S0021-9150(99)00272-5
Mela M, Grötzner SR, Legeay A, Mesmer-Dudons N, Massabuau J-C, Ventura DF, et al. Morphological evidence of neurotoxicity in retina after methylmercury exposure. Neurotoxicology. 2012;33:407–15.
pubmed: 22531226
doi: 10.1016/j.neuro.2012.04.009
Saldana M, Collins CE, Gale R, Backhouse O. Diet-related mercury poisoning resulting in visual loss. Br J Ophthalmol. 2006;90:1432–4.
pubmed: 17057175
pmcid: 1857490
doi: 10.1136/bjo.2006.094821
Ceylan OM, Demirdöğen BC, Mumcuoğlu T, Aykut O. Evaluation of essential and toxic trace elements in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Biol Trace Elem Res. 2013;153:28–34.
pubmed: 23512169
doi: 10.1007/s12011-013-9644-5
Carocci A, Rovito N, Sinicropi MS, Genchi G. Mercury toxicity and neurodegenerative effects. InReviews of environmental contamination and toxicology. Springer, Cham. p. 1–18. 2014.
Argun AA, Banks AM, Merlen G, Tempelman LA, Becker MF, Schuelke T, et al. Highly sensitive detection of urinary cadmium to assess personal exposure. Anal Chim Acta. 2013;773:45–51.
pubmed: 23561905
pmcid: 3622219
doi: 10.1016/j.aca.2013.02.034
Raymond J, Wheeler W, Brown MJ. Lead screening and prevalence of blood lead levels in children aged 1–2 years—Child blood lead surveillance system, United States, 2002–2010 and national health and nutrition examination survey, United States, 1999–2010. Morb Mortal Wkly Rep. 2014;63:36–42.
Nunes LS, Lemos VA. Ultrasound-Assisted Emulsification Microextraction in an Online System for Determination of Cadmium in Water and Tea Samples. Journal of AOAC International. 2018;101:1647–52.
pubmed: 29571304
doi: 10.5740/jaoacint.17-0128
Zeng Y, Ren J, Shen A, Hu J. Field and pretreatment-free detection of heavy-metal ions in organic polluted water through an alkyne-coded SERS test kit. ACS Appl Mater Interfaces. 2016;8:27772–8.
pubmed: 27696801
doi: 10.1021/acsami.6b09722
Prevention (CDC C for DC and. Update: blood lead levels–United States, 1991–1994. MMWR Morb Mortal Wkly Rep. 1997;46:141–64.
Thomas VM. The elimination of lead in gasoline. Annu Rev Energy Environ. 1995;20:301–24.
doi: 10.1146/annurev.eg.20.110195.001505
Ikeda M, Watanabe T, Nakatsuka H, Moriguchi J, Sakuragi S, Ohashi F, et al. Cadmium exposure in general populations in Japan: a review. Food Saf. 2015;3:118–35.
doi: 10.14252/foodsafetyfscj.2015020